Tobacco Products Toxicology Study

The contract involves a research project aimed at assessing the toxicity, genotoxicity, and mutagenicity of various components commonly found in tobacco products under current review as well as recently authorized items like electronic nicotine delivery systems (ENDS), nicotine pouches, and waterpipe tobacco. The study focuses on ingredients, leachables, flavors, and metals present in these products to provide critical toxicological data. These findings will be instrumental in guiding the Food and Drug Administration’s (FDA) tobacco product review process, aiding in the development of product standards, and shaping potential future guidance related to toxicological assessments in tobacco regulation. Managed by the FDA, this initiative falls under the NAICS code 541618 and does not specify a set-aside or particular organization type. The contract details indicate it is a forecast solicitation posted in March 2026, with points of contact including a program acquisition liaison and a contracting officer yet to be determined. The project’s outcomes are intended to enhance regulatory science efforts by providing robust toxicological information critical for evaluating the safety and standards of emerging and existing tobacco products.